Performance indicators

Oncology: in Basilicata, patients are seen quickly and treatment begins within 16 days

The initial findings of the project evaluating the regional cancer network have been presented: high levels of patient satisfaction

Computer Screen in Hospital Radiology Room: Beautiful Multiethnic Adult Woman Standing Topless Undergoing Mammography Screening Procedure. Screen Showing the Mammogram Scans of Dense Breast Tissues. Gorodenkoff - stock.adobe.com

3' min read

Translated by AI
Versione italiana

3' min read

Translated by AI
Versione italiana

To assess the quality of cancer care in order to identify strengths and opportunities for improvement in treatment pathways. This is the aim of the Val.Pe.ROB project – Evaluation of the Basilicata Oncology Network’s Care Pathways – carried out by the IRCCS CROB in collaboration with the Department of Business and Quantitative Studies (DISaQ) at the University of Naples Parthenope, through the Vimass research laboratory.

The initial results of the pilot project were presented at the Enzo Cervellino Auditorium of the IRCCS CROB in Rionero in Vulture, as part of an institutional conference dedicated to evaluating the performance of the Basilicata Oncology Network. The meeting brought together healthcare professionals, researchers and representatives from various institutions, providing an important opportunity to discuss the results achieved and future prospects for improving regional cancer care.

Loading...

Val.Pe.ROB: measuring to improve cancer care

The project was launched with the aim of monitoring the quality and efficiency of care pathways within the Basilicata Oncology Network through the development of a multidimensional dashboard of key performance indicators (KPIs). The tool has been designed to assess various aspects of cancer care over time, integrating clinical, organisational and patient-experience dimensions. The aim is to provide healthcare decision-makers with useful information to support decision-making processes, identify any critical issues and promote the continuous improvement of services. Performance measurement is, in fact, a fundamental element of healthcare governance that is increasingly focused on quality, efficiency and placing the patient at the centre of the care pathway.

Treatment times and patient satisfaction: initial results

The pilot phase involved 70 patients with breast cancer between July 2024 and May 2025, analysing nine indicators relating to the duration of the care pathway and patient satisfaction. The results paint an encouraging picture, particularly with regard to the timeliness of treatment decisions. On average, 9 days elapse between the first consultation with the Multidisciplinary Oncology Team (MOT) and the finalisation of the treatment decision, whilst the average time between the decision and the start of treatment is 16 days.

Positive feedback has also emerged from patients’ experiences, with satisfaction levels ranging from 4.5 to 4.8 out of 5. The highest ratings relate to the quality of medical care, the attentiveness of healthcare staff and respect for privacy. This initial evidence provides an important knowledge base for consolidating the strengths of the care pathway and identifying further opportunities for improvement, through an approach based on the systematic measurement of outcomes.

Crob and Parthenope University: a partnership for innovation in healthcare

The collaboration between the IRCCS CROB and the University of Naples Parthenope is an example of the integration of clinical, organisational and managerial expertise, aimed at developing innovative tools for the assessment and improvement of cancer care.

‘The evaluation of clinical pathways is not merely an act of transparency, but the true driving force behind our continuous improvement. With the results of the Val.Pe.ROB pilot project, the IRCCS CROB in Rionero in Vulture reaffirms its commitment to innovation, aiming to constantly measure and optimise the quality of care provided to the public. Placing organisational efficiency and patient care at the centre is key to consolidating our Institute’s position as a benchmark of excellence, not only for Basilicata and its regional cancer network but for the whole of Southern Italy. ‘I would like to thank our academic partners at the VIMASS Lab of Parthenope University for their invaluable scientific and methodological collaboration,’ said Massimo De Fino, Director-General of the IRCCS CROB.

Future prospects: regional accessibility and telemedicine

During the conference, particular attention was also paid to the regional dimension of cancer care and to telemedicine.

The future objective of the Val.Pe.ROB project, carried out with unrestricted funding from Novartis, Merck and Pfizer, is to consolidate and expand the performance monitoring system of the Basilicata Oncology Network, gradually integrating further dimensions of analysis and making the most of the opportunities offered by organisational and technological innovation.

This approach is in line with the principles of Person-Centred Care, a model of care that places the individual at the centre of the care pathway, recognising their needs, preferences and active role in decisions concerning their own health.

Copyright reserved ©
Loading...
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti